On Tuesday, Kura Oncology Inc (NASDAQ: KURA) opened higher 1.79% from the last session, before settling in for the closing price of $7.26. Price fluctuations for KURA have ranged from $6.98 to $24.17 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -14.67% at the time writing. With a float of $65.23 million, this company’s outstanding shares have now reached $77.75 million.
In an organization with 142 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 48.82%, operating margin of -17126.14%, and the pretax margin is -15555.28%.
Kura Oncology Inc (KURA) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Kura Oncology Inc is 16.12%, while institutional ownership is 97.49%. The most recent insider transaction that took place on Nov 18 ’24, was worth 8,434. In this transaction Chief Operating Officer of this company sold 526 shares at a rate of $16.03, taking the stock ownership to the 23,184 shares. Before that another transaction happened on Nov 18 ’24, when Company’s Officer proposed sale 526 for $15.99, making the entire transaction worth $8,410.
Kura Oncology Inc (KURA) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.65 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -14.67% per share during the next fiscal year.
Kura Oncology Inc (NASDAQ: KURA) Trading Performance Indicators
Check out the current performance indicators for Kura Oncology Inc (KURA). In the past quarter, the stock posted a quick ratio of 11.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.36, a number that is poised to hit -0.64 in the next quarter and is forecasted to reach -1.96 in one year’s time.
Technical Analysis of Kura Oncology Inc (KURA)
Let’s dig in a bit further. During the last 5-days, its volume was 1.53 million. That was better than the volume of 1.52 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 17.88%. Additionally, its Average True Range was 0.43.
During the past 100 days, Kura Oncology Inc’s (KURA) raw stochastic average was set at 2.81%, which indicates a significant decrease from 21.58% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 37.66% in the past 14 days, which was lower than the 81.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.99, while its 200-day Moving Average is $17.71. However, in the short run, Kura Oncology Inc’s stock first resistance to watch stands at $7.48. Second resistance stands at $7.58. The third major resistance level sits at $7.72. If the price goes on to break the first support level at $7.25, it is likely to go to the next support level at $7.11. The third support level lies at $7.01 if the price breaches the second support level.
Kura Oncology Inc (NASDAQ: KURA) Key Stats
There are currently 77,764K shares outstanding in the company with a market cap of 574.67 million. Presently, the company’s annual sales total 0 K according to its annual income of -152,630 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -54,400 K.
